- A549 00h 100 nM dexamethasone
- A549 01h 100 nM dexamethasone
- A549 04h 100 nM dexamethasone
- A549 08h 100 nM dexamethasone
- A549 12h 100 nM dexamethasone
- ADAC418 (primary islet)
- Adrenal gland
- Aorta
- ASCs (Adipose-Derived Stem Cells), 0 day of differentiation induction
- ASCs (Adipose-Derived Stem Cells), 1 day after neuronal induction
- ASCs (Adipose-Derived Stem Cells), 1 day of differentiation induction
- ASCs (Adipose-Derived Stem Cells), 2 days before induction of differentiation
- ASCs (Adipose-Derived Stem Cells), 3 day after neuronal induction
- ASCs (Adipose-Derived Stem Cells), 3 day of differentiation induction
- astrocyte of the cerebellum primary cell
- astrocyte of the spinal cord primary cell
- B cells
- B cells
- Bladder
- brain microvascular endothelial primary cell
- brain pericyte primary cell
- CD4+ T cells
- CD4+ T cells, activated using anti-CD3/CD28 bead
- Dorsolateral Prefrontal Cortex
- Embryonic stem cell
- Embryonic stem cell, HERV-H1 CRISPRi
- Embryonic stem cell, HERV-H1 Knock-Out, HERV-H elements located TAD boundaries were deleted using CRISPR–Cas9
- Embryonic stem cell, HERV-H2 CRISPRi
- Embryonic stem cell, HERV-H2 Knock-Out, HERV-H elements located TAD boundaries were deleted using CRISPR–Cas9
- Embryonic stem cell, HERV-H2-insertion clone1
- Embryonic stem cell, HERV-H2-insertion clone2
- EndoC-βH1 cells (pancreatic beta cell line)
- endometrial microvascular endothelial primary cell
- endothelial of hepatic sinusoid primary cell
- fibroblast(CRL-2522) control
- fibroblast(CRL-2522) dexamethasone 00h
- fibroblast(CRL-2522) dexamethasone 08h
- fibroblast(CRL-2522) dexamethasone 16h
- fibroblast(CRL-2522) dexamethasone 24h
- fibroblast(CRL-2522) dexamethasone 32h
- fibroblast(CRL-2522) dexamethasone 40h
- fibroblast(CRL-2522) dexamethasone 48h
- fibroblast(CRL-2522) dexamethasone 56h
- GM23248 (primary skin fibroblasts)
- H1 Embroynic Stem Cell
- H1 Mesenchymal Stem Cell
- H1 Mesendoderm Cell
- H1 Neuronal Progenitor Cell
- H1 Trophectoderm Cell
- H9 human Embryonic Stem Cell Line, Heat shock condition
- H9 Human Embryonic Stem Cells
- H9 Human ESC-derived Neuroectodermal Cells
- HAP1 (near-haploid cell line)
- HAP1 (near-haploid cell line), SSC Knock Out
- HAP1 (near-haploid cell line), WAPL and SSC Knock OUT
- HAP1 (near-haploid cell line), WAPL knock Out
- HEK293T (embryonic kidney cell line), transfected with dCas9-VPR targeting the exon CTCF binding site of Pcdha12
- HEK293T (embryonic kidney cell line), transfected with dCas9-VPR targeting the promoter CTCF binding site of Pcdha12
- Hippocampus
- HTBE (human tracheobronchial epithelial cells), infect active H5N1 influenza, infection time 6hour
- HTBE (human tracheobronchial epithelial cells), infect active H5N1 influenza, infection time 12hour
- HTBE (human tracheobronchial epithelial cells), infect active H5N1 influenza, infection time 18hour
- HTBE (human tracheobronchial epithelial cells), infect mock, infection time 6hour
- HTBE (human tracheobronchial epithelial cells), infect mock, infection time 12hour
- HTBE (human tracheobronchial epithelial cells), infect mock, infection time 18hour
- HTBE (human tracheobronchial epithelial cells), infect UV-inactived H5N1 influenza, infection time 6hour
- HTBE (human tracheobronchial epithelial cells), infect UV-inactived H5N1 influenza, infection time 12hour
- HTBE (human tracheobronchial epithelial cells), infect UV-inactived H5N1 influenza, infection time 18hour
- Human Erythroid Progenitor cells (CD36+, CD71+, CD235a+)
- Human Hematopoietic Stem/Progenitor Cells (CD34+, CD38-)
- Human T cell (CD3+)
- HUVEC (Human umbilical vein endothelial cells), donor1
- HUVEC (Human umbilical vein endothelial cells), donor1, Oncogenic induced senescence
- HUVEC (Human umbilical vein endothelial cells), donor2
- HUVEC (Human umbilical vein endothelial cells), donor2, Oncogenic induced senescence
- HUVEC (Human umbilical vein endothelial cells), donor2, Oncogenic induced senescence, treated with non-targeting control siRNA
- HUVEC (Human umbilical vein endothelial cells), donor3
- HUVEC (Human umbilical vein endothelial cells), donor3, Oncogenic induced senescence
- HUVEC (Human umbilical vein endothelial cells), treated with siRNA targeting HMGB2 (HMGB2-Knock Down)
- HUVEC (umblical vein endothelial cells)
- HUVEC (umblical vein endothelial cells), treated 10 ng/ml TNF-α, 1hour
- HUVEC, in-situ MboI
- IMR90 (fetal lung fibroblast cell), I10
- IMR90 (fetal lung fibroblast cell), I10, Oncogenic induced senescence
- IMR90 (fetal lung fibroblast cell), I79
- IMR90 (fetal lung fibroblast cell), I79, Oncogenic induced senescence
- IMR90, in-situ MboI
- K562, in-situ MboI
- KBM7 cell line
- KBM7, in-situ MboI
- Left Ventricle
- Liver
- LNCap prostate cancer cell line, BglII
- Lung
- MCF-10A
- MCF-10A BRG1 shRNA
- MCF-10A scramble shRNA
- MCF-7
- MCF-7 non-specific shRNA
- MCF-7 RUNX1 shRNA
- MCF10a (epithelial cell line), arrested in G1
- MCF10a (epithelial cell line), arrested in G1 and transfected STAG1 siRNA
- MCF10a (epithelial cell line), arrested in G1 and transfected STAG2 siRNA
- MDM (monocyte-derived macrophages), infect active H5N1 influenza, infection time 6hour
- MDM (monocyte-derived macrophages), infect active H5N1 influenza, infection time 12hour
- MDM (monocyte-derived macrophages), infect active H5N1 influenza, infection time 18hour
- MDM (monocyte-derived macrophages), infect H5N1-dNS1 influenza, infection time 6hour
- MDM (monocyte-derived macrophages), infect mock, infection time 6hour
- MDM (monocyte-derived macrophages), infect mock, infection time 12hour
- MDM (monocyte-derived macrophages), infect mock, infection time 18hour
- MDM (monocyte-derived macrophages), infect UV-inactived H5N1 influenza, infection time 6hour
- MDM (monocyte-derived macrophages), infect UV-inactived H5N1 influenza, infection time 12hour
- MDM (monocyte-derived macrophages), infect UV-inactived H5N1 influenza, infection time 18hour
- MDM (monocyte-derived macrophages), treat IFNb, 6hour
- MSC (mesenchymal stromal cells)
- MSC (mesenchymal stromal cells), Oncogenic induced senescence
- NA
- NA
- NA
- Naïve CD4+ T cells
- Naïve CD4+ T cells
- Naïve CD8+ T cells
- Naïve CD8+ T cells
- Naïve human embryonic stem cells, growth condition: GSKi + MEKi (2i), Lif, IGF1, FGF
- NHEK, in-situ MboI
- Ovary
- Pancreas
- PC3 prostate cancer cell line, BglII
- Peripheral blood neutrophils
- Peripheral blood neutrophils, co-cultured with E.coli K1, 3hour
- Peripheral blood neutrophils, treat 25nM PMA, 3hour
- PrEC normal Prostate epithelial cell, BglII
- primary epidermal keratinocyte, Differentiation Day 0
- primary epidermal keratinocyte, Differentiation Day 3
- primary epidermal keratinocyte, Differentiation Day 6
- primary white blood cell
- Psoas
- purified human germinal center B cells
- purified human naïve B cells
- Right Ventricle
- RUES2 (Embryonic stem cells), cardiac differentiation stage : cardiac progenitor (CP)
- RUES2 (Embryonic stem cells), cardiac differentiation stage : cardiomyocytes (CM)
- RUES2 (Embryonic stem cells), cardiac differentiation stage : Embryonic stem cells (ESC)
- RUES2 (Embryonic stem cells), cardiac differentiation stage : mesoderm (MES)
- RUES2 (Embryonic stem cells), fetal heart
- RWPE1 (prostate cell line)
- SK-N-DZ Cell Line
- Small Bowel
- Spleen
- teloHAEC (endothelial cell line)
- teloHAEC (endothelial cell line), TNFα treated, 4hour
- Thymus
- WTC-11 (iPSCs), cardiac differentiation stage : cardiac progenitor (CP)
- WTC-11 (iPSCs), cardiac differentiation stage : cardiomyocytes (CM)
- WTC-11 (iPSCs), cardiac differentiation stage : mesoderm (MES)
- WTC-11 (iPSCs), cardiac differentiation stage : pluripotent stem cells (PSC)
Bait :
(Ex.chr22:26641000-27641000)
No. | Sample | Bait | TAD |
---|
Gene symbols
IP address :
(Ex. http://biodb.kaist.ac.kr/hic_db/Data_AD.ktm )
Bait :
(Ex. chr10:4000000)
Interaction range :